Skip to main content
OpenTrials

Clinical trial condition

Depressive Disorder, Major

Explore clinical trials studying Depressive Disorder, Major. Study availability and eligibility vary by location and protocol.

2,290 public trials 323 recruiting studies
Refine in advanced search Browse all conditions

Depressive Disorder, Major trial results

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder

NCT00863798

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Encino, California, United States
  • Pfizer Investigational Site Newport Beach, California, United States
  • Pfizer Investigational Site Redlands, California, United States
View all 24 locations
View Trial Details
Completed

Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder

NCT01309542

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • Birmingham Research Group Inc. Birmingham, Alabama, United States
  • Pivotal Research Centers 13128 North 94th Drive, Suite 200 Mesa, Arizona, United States
  • Pivotal Research Peoria, Arizona, United States
  • Southwestern Research, Inc. Beverly Hills, California, United States
View all 117 locations
View Trial Details
Completed

A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder

NCT01034995

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depression, +2 more
Locations
  • Sanofi-Aventis Investigational Site Number 056002 Asse, Belgium
  • Sanofi-Aventis Investigational Site Number 056003 Brussels, Belgium
  • Sanofi-Aventis Investigational Site Number 056001 Liège, Belgium
  • Sanofi-Aventis Investigational Site Number 124011 Burlington, Canada
View all 73 locations
View Trial Details
Completed

Effects Of Antidepressants On Sexual Functioning In Adults

NCT00051272

Conditions
Behavior, Behavioral Symptoms, Depression, +9 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Berkeley, California, United States
  • GSK Investigational Site Middletown, Connecticut, United States
View all 24 locations
View Trial Details
Completed

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder

NCT00619619

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site North Miami, Florida, United States
  • Pfizer Investigational Site Terre Haute, Indiana, United States
  • Pfizer Investigational Site Wichita, Kansas, United States
View Trial Details
Completed

Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder

NCT00351910

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • Research Site Everton Park, Queensland, Australia
  • Research Site Southport, Queensland, Australia
  • Research Site Frankston, Victoria, Australia
  • Research Site Malvern, Victoria, Australia
View all 72 locations
View Trial Details

Related conditions